|Vaccination / Manufacturer
||Lot / Dose
||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.
||- / 1
||UN / IM
Administered by: Other Purchased by: Other
Symptoms: Abdominal pain,
Loss of personal independence in daily activities,
Tilt table test normal
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Asthma/bronchospasm (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Dementia (broad), Dystonia (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Cardiomyopathy (broad), Corneal disorders (broad), Eosinophilic pneumonia (broad), Retinal disorders (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)
Life Threatening? No
Birth Defect? No
Permanent Disability? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Other Medications: No other medications
Current Illness: Immunisation
Diagnostic Lab Data: Based on tilt table test the patient does not fulfill the diagnostic criteria for POTS.
CDC Split Type: WAES1602DNK010684
Write-up: Information has been received from Sanofi Pasteur MSD (reference # DK-1577272925-2016001456) on 22-FEB-2016. Abdominal pain, cognitive disorder, cramp muscle, dizziness, dry mouth, fatigue extreme, headache, hyperventilation, light sensitivity to eye, menstrual disorder, near syncope, neuropathic pain, palpitation, shortness of breath, sleep disorder, temperature intolerance, voiding difficulty, weakness of arms. Follow up information received on 17-Feb-2016 from the HA. Adverse events reported: Abdominal pain, cognitive disorder, cramp muscle, dizziness, dry mouth, fatigue extreme, headache, hyperventilation, light sensitivity to eye, menstrual disorder, near syncope, neuropathic pain, palpitation, shortness of breath, sleep disorder, temperature intolerance, voiding difficulty, weakness of arms. The patient informs, that her onset of symptoms started after dose 1 GARDASIL. She developed dizziness and vomiting. Thereafter, she suffered from stomach- and back pain and headache. The other symptoms has subsequently developed. The patient describes that she prior to the vaccination was a very active girl- energetic. As a consequence, she had high absence in school 7 to 9th grade. The tilt table test shows that the patient does not fulfill the diagnostic criteria for POTS. Other vaccines/medicines: unknown.